Abstract:OBJECTIVE:To establish a nested case-control study cohort in myelodysplastic syndrome (MDS) patients and investigate the clinical characteristics, WHO subtype and risk factors associated with MDS evolution to leukemia of this cohort.METHODS:All patients, ≥18 years of age, provided by 24 Shanghai hospitals with initial clinical findings consistent with a hematopoietic abnormality between June 2003 and April 2007, were the candidates for inclusion in this study. The blood and bone marrow samples of every patient should be provided at baseline. Diagnosis was made by incorporating morphologic, immunophenotypic, cytogenetic and molecular features according to WHO classification criteria. Cytogenetic analysis was performed using conventional G-banding karyotyping and fluorescence in situ hybridization (FISH) techniques. Cumulative risk of evolution was estimated by Kaplan-Meier method. Prognostic factors were evaluated by univariate Log-rank method and multivariate Cox proportional hazard models.RESULTS:A total of 435 patients were diagnosed as MDS. The median age of MDS onset was 58(18-90) years, with 248 male patients and 187 female patients (male: female 1.33: 1). The percentage of cases with refractory cytopenia with multilineage dysplasia (RCMD) was the highest (65.5%), while that of refraetory anemia (RA) (2.3%), refractory anenia with ring sideroblast (RARS) (1.1%) and 5q-syndrome (0.5%) was lower. Trisomy 8 (+8) was the most common chromosome abnormalities (71 cases, 12.7%). The mean follow-up time was 20.3 (4.2-57.1) months. Cases were patients with evolution by the end of follow-up, while controls were patients without evolution by that time. Case group included 41 patients and control group included 342 patients. Univariate analysis showed that the age, sex, WHO subtype, WBC count, absolute neutrophil count (ANC), IPSS cytogenetic subgroup, IPSS group and bone marrow blast percentage were significant risk factors for leukemia-free survival (LFS). Multivariate analysis of COX model showed that the age, sex, WHO subtype, IPSS cytogenetic subgroup and bone marrow blast were independent risk factors for LFS.CONCLUSION:A nested case-control study cohort of MDS patients is established. The clinical characteristics and WHO subtype of MDS patients in Chinese Shanghai are different from that in Western countries. The independent risk factors for MDS evolution are age, sex, WHO subtype, IPSS cytogenetic subgroup and bone marrow blast percentage.

[A case-control study of risk factors for myelodysplastic syndromes]

Case-Control Study of Risk Factors of Myelodysplastic Syndromes According to World Health Organization Classification in A Chinese Population

Pesticide Exposure As a Risk Factor for Myelodysplastic Syndromes: a Meta-Analysis Based on 1,942 Cases and 5,359 Controls.

A Meta-Analysis Of The Relationship Between Cigarette Smoking And Incidence Of Myelodysplastic Syndromes

Case Control Study on Relationship Between Hair Dye Use and Myeloid Dysplastic Syndrome

Hospital-Based Case-Control Study of MDS Subtypes and Benzene Exposure in Shanghai.

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

Risk Factors for Acute Myeloid Leukemia in Adults: a Hospital-Based Case-Control Study

Associations of Parental Occupational Exposure to Extremely Low-Frequency Magnetic Fields with Childhood Leukemia Risk

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

Integrating WHO 2001–2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): A case–case analysis of benzene exposure

A Case-Control Study Of Chronic Myelomonocytic Leukemia (Cmml) In Shanghai, China: Evaluation Of Risk Factors For Cmml, With Special Focus On Benzene

A Hospital-Based Case Control Study of Aplastic Anemia in Shanghai, China

[Establishment of Primary Adult MDS Nested Case-Control Study Cohort and Study of Risk Factors Associated with MDS Evolution to Leukemia].

A Hospital-Based Case-Control Study of Acute Myeloid Leukemia in Shanghai: Analysis of Personal Characteristics, Lifestyle and Environmental Risk Factors by Subtypes of the WHO Classification

Myelodysplastic syndromes:a clinical analysis of 50 cases

Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece

Multicentre Hospital-Based Case-Control Study Of Diffuse Large B-Cell Lymphoma In Shanghai, China

Prevalence Of Mds In Shanghai, China Using The Who Classification.

[Prospective Clinical Study of Diagnosis and Classification for 282 Cases with Primary Myelodysplastic Syndrome].

Case control study on risk factors of malign blood system disease